Bayesian Futility Monitoring
Bay筼esian Futility Monitoring is a Bayesian adaptive trial design methodology that uses accumulating evidence to assess the probability of a treatment failing to achieve a clinically meaningful effect, thereby enabling early termination of a study if posterior predictive probabilities indicate insufficient benefit.
2
Publications
61
Citations
29
Authors
15
Institutions
Publications per year
2017–2026
2
Parents
2
Lindsay J. Collin, Richard F. MacLehose, Thomas P. Ahern et al. · Epidemiology · 2020 · 13 citations · Full text
1–2 of 2
29
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 29
15
Emory University
Atlanta, United States
2 h-index
6 publications
148 citations

University of Minnesota
Minneapolis, United States
1 h-index
1 publications
13 citations

University of Vermont
Burlington, United States
1 h-index
1 publications
13 citations
Moffitt Cancer Center
Tampa, United States
1 h-index
2 publications
96 citations
Kaiser Permanente
Oakland, United States
1 h-index
3 publications
39 citations
Winship Cancer Institute
Atlanta, United States
1 h-index
2 publications
96 citations
Medical University of South Carolina
Charleston, United States
1 h-index
1 publications
48 citations
University of Arizona
Tucson, United States
1 h-index
5 publications
240 citations
1–8 of 15
1 publications · 48 citations
1
h-index
1 publications · 13 citations
1
h-index
1–2